Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
INTS
#3863
Intensity Therapeutics, Inc. Common stock
7.6
6
+4.64%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+4.64%
Aylık değişim
+1915.79%
6 aylık değişim
+2541.38%
Yıllık değişim
+234.50%
Önceki kapanış
7.3
2
Open
7.6
6
Bid
Ask
Low
7.6
6
High
7.6
6
Hacim
1
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
INTS
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
TTM
Key stats
Total common shares outstanding
548.38 K
607.24 K
—
Valuation ratios
Enterprise value
-3.8 M
-1.52 M
-9.12 M
Price to earnings ratio
-0.25
-0.06
-0.17
Price to sales ratio
1.32
—
—
Price to cash flow ratio
0.41
0.06
0.18
Price to book ratio
0.23
0.34
0.47
Enterprise value to EBITDA ratio
—
—
—
Profitability ratios
Return on assets %
0.61
3.41
2.6
Return on equity %
0.8
5.59
12.51
Return on invested capital %
1 797.73
4 021.82
—
Gross margin %
100
—
—
Operating margin %
367.77
—
—
EBITDA margin %
—
—
—
Net margin %
464.19
—
—
Liquidity ratios
Quick ratio
—
—
—
Current ratio
3.91
1.92
7.54
Inventory turnover
—
—
—
Asset turnover
0.13
0
—
Solvency ratios
Debt to assets ratio
—
—
—
Debt to equity ratio
—
—
—
Long term debt to total assets ratio
—
—
—
Long term debt to total equity ratio
—
—
—
Per share metrics
Operating cash flow per share
20.91
27.36
12.71
EBIT per share
—
—
—
EBITDA per share
—
—
—
Total debt per share
—
—
—
Cash per share
42.94
4.67
13.2
Net current asset value per share
44.87
6.05
17.55
Tangible book value per share
38.19
5.25
12.88
Working capital per share
33.38
2.89
5.87
Book value per share
38.19
5.25
12.88
Haberler
Intensity Therapeutics 1’e 25 ters hisse bölünmesi duyurdu
Intensity Therapeutics announces 1-for-25 reverse stock split
What's Going On With Intensity Therapeutics Stock Friday? - Intensity Therapeutics (NASDAQ:INTS)
Intensity Therapeutics, klinik doğrulama sonrası 2026 önceliklerini açıkladı
Intensity therapeutics outlines 2026 priorities after clinical validation
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy
Intensity Therapeutics hisseleri Nasdaq listesinde kalma süresini uzattı
Intensity Therapeutics stock rises after securing Nasdaq listing extension
Intensity Therapeutics, Nasdaq fiyat kuralına uyum için 180 günlük uzatma aldı
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule
Intensity Therapeutics ATM programını 30 milyon dolara genişletti
Intensity Therapeutics expands at-the-market offering program to $30 million